Last 12 months
Inside the activity.
0 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 9 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 05, 2024 Filed Jan 8, 2024 18:23 UTC |
Galbraith KennethDirector · Chair & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 47,666 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-003099 · ownership.xml · derivative · entry 4 Galbraith Kenneth · CIK 0001567045 · Director · Chair & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,334 Underlying: Common Stock · 47,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F6 · derivative.exercise_date: The RSUS were granted on January 5, 2023 and vest in three equal annual installments beginning on January 5, 2024. F6 · derivative.expiration_date: The RSUS were granted on January 5, 2023 and vest in three equal annual installments beginning on January 5, 2024. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 18:23 UTC |
Galbraith KennethDirector · Chair & CEO
|
SaleCommon Stock | 18,198 | $10.65 | $193,848.74 |
DisclosureSEC source: 0000950170-24-003099 · ownership.xml · nonDerivative · entry 2 Galbraith Kenneth · CIK 0001567045 · Director · Chair & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,468 F2 · kind: Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.55 to $10.845, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 18:23 UTC |
Galbraith KennethDirector · Chair & CEO
|
Exercise / conversionCommon Stock | 47,666 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-003099 · ownership.xml · nonDerivative · entry 1 Galbraith Kenneth · CIK 0001567045 · Director · Chair & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares of common stock issued upon vesting of one third of the restricted stock units ("RSUs") granted on January 5, 2023. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 18:00 UTC |
Smith Jeffrey T LEVP & Chief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-003065 · ownership.xml · derivative · entry 2 Smith Jeffrey T L · CIK 0001604800 · EVP & Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs vest in three equal annual installments beginning on January 5, 2025. F3 · derivative.expiration_date: The RSUs vest in three equal annual installments beginning on January 5, 2025. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 18:00 UTC |
Smith Jeffrey T LEVP & Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $10.56 | $0.00 |
DisclosureSEC source: 0000950170-24-003065 · ownership.xml · derivative · entry 1 Smith Jeffrey T L · CIK 0001604800 · EVP & Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2034-01-04 F1 · derivative.exercise_date: Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 18:14 UTC |
Astle ChristopherSVP & Chief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-003087 · ownership.xml · derivative · entry 6 Astle Christopher · CIK 0001915257 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F5 · derivative.exercise_price: Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F8 · derivative.exercise_date: The RSUs vest in three equal annual installments beginning on January 5, 2025. F8 · derivative.expiration_date: The RSUs vest in three equal annual installments beginning on January 5, 2025. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 18:14 UTC |
Astle ChristopherSVP & Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $10.56 | $0.00 |
DisclosureSEC source: 0000950170-24-003087 · ownership.xml · derivative · entry 5 Astle Christopher · CIK 0001915257 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-01-04 F7 · derivative.exercise_date: Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 18:14 UTC |
Astle ChristopherSVP & Chief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 10,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-003087 · ownership.xml · derivative · entry 4 Astle Christopher · CIK 0001915257 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 10,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F6 · derivative.exercise_date: The RSUS were granted on January 5, 2023 and vest in three equal annual installments beginning on January 5, 2024. F6 · derivative.expiration_date: The RSUS were granted on January 5, 2023 and vest in three equal annual installments beginning on January 5, 2024. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 18:14 UTC |
Astle ChristopherSVP & Chief Financial Officer
|
SaleCommon Stock | 4,563 | $10.65 | $48,605.99 |
DisclosureSEC source: 0000950170-24-003087 · ownership.xml · nonDerivative · entry 2 Astle Christopher · CIK 0001915257 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,934 F2 · kind: Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.55 to $10.845, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 18:14 UTC |
Astle ChristopherSVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 10,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-003087 · ownership.xml · nonDerivative · entry 1 Astle Christopher · CIK 0001915257 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares of common stock issued upon vesting of one third of the restricted stock units ("RSUs") granted on January 5, 2023. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 23:01 UTC |
Moore Paul AndrewChief Scientific Officer
|
GrantRestricted Stock Unit · Derivative | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-003076 · ownership.xml · derivative · entry 6 Moore Paul Andrew · CIK 0001938192 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires not disclosed F5 · derivative.exercise_price: Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F8 · derivative.exercise_date: The RSUs vest in three equal annual installments beginning on January 5, 2025. F8 · derivative.expiration_date: The RSUs vest in three equal annual installments beginning on January 5, 2025. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 23:01 UTC |
Moore Paul AndrewChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $10.56 | $0.00 |
DisclosureSEC source: 0000950170-24-003076 · ownership.xml · derivative · entry 5 Moore Paul Andrew · CIK 0001938192 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2034-01-04 F7 · derivative.exercise_date: Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 23:01 UTC |
Moore Paul AndrewChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 17,166 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-003076 · ownership.xml · derivative · entry 4 Moore Paul Andrew · CIK 0001938192 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,334 Underlying: Common Stock · 17,166 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F6 · derivative.exercise_date: The RSUS were granted on January 5, 2023 and vest in three equal annual installments beginning on January 5, 2024. F6 · derivative.expiration_date: The RSUS were granted on January 5, 2023 and vest in three equal annual installments beginning on January 5, 2024. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 23:01 UTC |
Moore Paul AndrewChief Scientific Officer
|
SaleCommon Stock | 7,460 | $10.65 | $79,465.41 |
DisclosureSEC source: 0000950170-24-003076 · ownership.xml · nonDerivative · entry 2 Moore Paul Andrew · CIK 0001938192 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,706 F2 · kind: Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.55 to $10.845, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 23:01 UTC |
Moore Paul AndrewChief Scientific Officer
|
Exercise / conversionCommon Stock | 17,166 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-003076 · ownership.xml · nonDerivative · entry 1 Moore Paul Andrew · CIK 0001938192 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares of common stock issued upon vesting of one third of the restricted stock units ("RSUs") granted on January 5, 2023. Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 17:11 UTC |
EcoR1 Capital, LLC10% owner
|
PurchasePre-Funded Warrants · Derivative | 5,086,521 | $9.83 Strike: $0.00 | $49,999,992.78 |
DisclosureSEC source: 0000935836-23-000743 · ownership.xml · derivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See note Disclosed balance after: 5,086,521 Underlying: Common Stock · 5,086,521 shares Expires not disclosed F2 · shares: Qualified Fund purchased 4,818,462 of the pre-funded warrants reported in this transaction. F3 · derivative.expiration_date: The pre-funded warrants do not have an expiration date. F4 · derivative.underlying_shares: Each pre-funded warrant will be exercisable to purchase one share of Common Stock, except that the pre-funded warrants cannot be exercised if, after giving effect or immediately prior to such exercise, the reporting person, together with its affiliates and any other persons whose beneficial ownership of shares of Common Stock would be aggregated with the reporting person for purposes of Section 13(d) of the Securities Exchange Act of 1934 would beneficially own more than 19.99% of the total number of issued and outstanding shares of Common Stock or voting power of the issuer following such exercise. F5 · balance_after: After this transaction, Qualified Fund owned 4,818,462 of the pre-funded warrants. F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 26, 2023 Filed Dec 24, 2024 00:53 UTC |
EcoR1 Capital, LLC10% owner
|
PurchasePre-Funded Warrants · Derivative | 5,086,521 | $9.83 Strike: $0.00 | $49,999,992.78 |
DisclosureSEC source: 0000935836-24-000774 · ownership.xml · derivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See note Disclosed balance after: 5,086,521 Underlying: Common Stock · 5,086,521 shares Expires not disclosed F2 · shares: Qualified Fund purchased 4,818,462 of the pre-funded warrants reported in this transaction. F3 · derivative.expiration_date: The pre-funded warrants do not have an expiration date. F4 · derivative.underlying_shares: Each pre-funded warrant will be exercisable to purchase one share of Common Stock, except that the pre-funded warrants cannot be exercised if, after giving effect or immediately prior to such exercise, the reporting person, together with its affiliates and any other persons whose beneficial ownership of shares of Common Stock would be aggregated with the reporting person for purposes of Section 13(d) of the Securities Exchange Act of 1934 would beneficially own more than 19.99% of the total number of issued and outstanding shares of Common Stock or voting power of the issuer following such exercise. F5 · balance_after: After this transaction, Qualified Fund owned 4,818,462 of the pre-funded warrants. F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 11, 2023 Filed Dec 11, 2023 20:00 UTC |
Astle ChristopherSVP & Chief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-069496 · ownership.xml · derivative · entry 3 Astle Christopher · CIK 0001915257 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,550 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F5 · derivative.exercise_date: The RSUs were granted on December 10, 2021 and vested in two equal annual instalments (on December 12, 2022 and December 11, 2023). F5 · derivative.expiration_date: The RSUs were granted on December 10, 2021 and vested in two equal annual instalments (on December 12, 2022 and December 11, 2023). Read SEC document |
| December 11, 2023 Filed Dec 11, 2023 20:00 UTC |
Astle ChristopherSVP & Chief Financial Officer
|
SaleCommon Stock | 886 | $9.13 | $8,089.27 |
DisclosureSEC source: 0000950170-23-069496 · ownership.xml · nonDerivative · entry 2 Astle Christopher · CIK 0001915257 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,997 F2 · kind: Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.11 to $9.16, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 11, 2023 Filed Dec 11, 2023 20:00 UTC |
Astle ChristopherSVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 1,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-069496 · ownership.xml · nonDerivative · entry 1 Astle Christopher · CIK 0001915257 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares of common stock issued upon vesting of one half of the restricted stock units ("RSUs") granted on December 10, 2021. Read SEC document |
| December 07, 2023 Filed Dec 8, 2023 17:18 UTC |
Davidson NancyDirector
|
GrantStock Option (Right to Buy) · Derivative | 74,000 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0000950170-23-069108 · ownership.xml · derivative · entry 1 Davidson Nancy · CIK 0002002946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,000 Underlying: Common Stock · 74,000 shares Expires 2033-12-06 F1 · derivative.exercise_date: Stock options vest in 36 equal monthly installments starting one month after grant date of December 7, 2023. Read SEC document |
| December 07, 2023 Filed Dec 8, 2023 17:17 UTC |
Hillan Kenneth J.Director
|
GrantStock Option (Right to Buy) · Derivative | 37,000 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0000950170-23-069104 · ownership.xml · derivative · entry 1 Hillan Kenneth J. · CIK 0001600359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,000 Underlying: Common Stock · 37,000 shares Expires 2033-12-06 F1 · derivative.exercise_date: Stock options vest on date of next annual general meeting following grant date of December 7, 2023. Read SEC document |
| December 07, 2023 Filed Dec 8, 2023 22:22 UTC |
Mahony SusanDirector
|
GrantStock Option (Right to Buy) · Derivative | 37,000 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0000950170-23-069112 · ownership.xml · derivative · entry 1 Mahony Susan · CIK 0001463321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,000 Underlying: Common Stock · 37,000 shares Expires 2033-12-06 F1 · derivative.exercise_date: Stock options vest on date of next annual general meeting following grant date of December 7, 2023. Read SEC document |
| December 07, 2023 Filed Dec 8, 2023 22:41 UTC |
RENTON HOLLINGSDirector
|
GrantStock Option (Right to Buy) · Derivative | 37,000 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0000950170-23-069121 · ownership.xml · derivative · entry 1 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,000 Underlying: Common Stock · 37,000 shares Expires 2033-12-06 F1 · derivative.exercise_date: Stock options vest on date of next annual general meeting following grant date of December 7, 2023. Read SEC document |
| December 07, 2023 Filed Dec 8, 2023 17:26 UTC |
Neu KelvinDirector
|
GrantStock Option (Right to Buy) · Derivative | 37,000 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0000950170-23-069116 · ownership.xml · derivative · entry 1 Neu Kelvin · CIK 0001554699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,000 Underlying: Common Stock · 37,000 shares Expires 2033-12-06 F1 · derivative.exercise_date: Stock options vest on date of next annual general meeting following grant date of December 7, 2023. Read SEC document |
| December 07, 2023 Filed Dec 8, 2023 22:26 UTC |
Cox TroyDirector
|
GrantStock Option (Right to Buy) · Derivative | 37,000 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0000950170-23-069115 · ownership.xml · derivative · entry 1 Cox Troy · CIK 0001696923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,000 Underlying: Common Stock · 37,000 shares Expires 2033-12-06 F1 · derivative.exercise_date: Stock options vest on date of next annual general meeting following grant date of December 7, 2023. Read SEC document |
| December 07, 2023 Filed Dec 8, 2023 17:48 UTC |
Campoy CarlosDirector
|
GrantStock Option (Right to Buy) · Derivative | 37,000 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0000950170-23-069126 · ownership.xml · derivative · entry 1 Campoy Carlos · CIK 0001761518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,000 Underlying: Common Stock · 37,000 shares Expires 2033-12-06 F1 · derivative.exercise_date: Stock options vest on date of next annual general meeting following grant date of December 7, 2023. Read SEC document |
| December 07, 2023 Filed Dec 8, 2023 22:20 UTC |
Miller Derek John MichaelDirector
|
GrantStock Option (Right to Buy) · Derivative | 37,000 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0000950170-23-069111 · ownership.xml · derivative · entry 1 Miller Derek John Michael · CIK 0001971973 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,000 Underlying: Common Stock · 37,000 shares Expires 2033-12-06 F1 · derivative.exercise_date: Stock options vest on date of next annual general meeting following grant date of December 7, 2023. Read SEC document |
| June 30, 2023 Filed Jun 30, 2023 20:05 UTC |
Campoy CarlosDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $8.64 | $0.00 |
DisclosureSEC source: 0000950170-23-031230 · ownership.xml · derivative · entry 1 Campoy Carlos · CIK 0001761518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-06-29 F1 · derivative.exercise_date: Stock options vest in 36 equal monthly installments starting one month after grant date of June 30, 2023. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:04 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseCommon Stock | 3,350,000 | $8.12 | $27,202,000.00 |
DisclosureSEC source: 0000935836-23-000469 · ownership.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Note Disclosed balance after: 13,437,473 F2 · shares: Qualified Fund purchased 3,157,542 of the shares purchased in this transaction. F3 · balance_after: After this transaction, Qualified Fund directly owned 12,658,224 shares of the Common Stock. F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group withn the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| April 10, 2023 Filed Apr 11, 2023 00:10 UTC |
Miller Derek John MichaelDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $9.37 | $0.00 |
DisclosureSEC source: 0000899243-23-011069 · doc4.xml · derivative · entry 1 Miller Derek John Michael · CIK 0001971973 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-04-09 F1 · derivative.exercise_date: Stock options vest in 36 equal monthly installments starting one month after grant date of April 10, 2023. Read SEC document |
| March 28, 2023 Filed Mar 30, 2023 21:47 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseCommon Stock | 200,000 | $8.00 | $1,600,000.00 |
DisclosureSEC source: 0000935836-23-000348 · form4.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See note Disclosed balance after: 10,087,473 F2 · shares: Qualified Fund purchased 188,520 of the shares purchased in this transaction. F3 · balance_after: After this transaction, Qualified Fund directly owned 9,500,682 shares of the Common Stock. F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The Filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 17:00 UTC |
Klompas Neil APresident & COO
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,708 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-008432 · doc4.xml · derivative · entry 6 Klompas Neil A · CIK 0001761857 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,709 Underlying: Common Stock · 2,708 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F7 · derivative.exercise_date: The RSUs were granted on March 10, 2021 and vest in three equal annual instalments beginning on March 10, 2022. F7 · derivative.expiration_date: The RSUs were granted on March 10, 2021 and vest in three equal annual instalments beginning on March 10, 2022. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 17:00 UTC |
Klompas Neil APresident & COO
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-008432 · doc4.xml · derivative · entry 5 Klompas Neil A · CIK 0001761857 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F6 · derivative.exercise_date: The RSUs were granted on March 10, 2020 and vest in three equal annual instalments beginning on March 10, 2021. F6 · derivative.expiration_date: The RSUs were granted on March 10, 2020 and vest in three equal annual instalments beginning on March 10, 2021. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 17:00 UTC |
Klompas Neil APresident & COO
|
SaleCommon Stock | 2,977 | $7.83 | $23,297.70 |
DisclosureSEC source: 0000899243-23-008432 · doc4.xml · nonDerivative · entry 3 Klompas Neil A · CIK 0001761857 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,032 F3 · kind: Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.815 to $7.86, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 17:00 UTC |
Klompas Neil APresident & COO
|
Exercise / conversionCommon Stock | 2,708 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-008432 · doc4.xml · nonDerivative · entry 2 Klompas Neil A · CIK 0001761857 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Represents shares of common stock issued upon vesting of one third of the RSUs granted on March 10, 2021. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 17:00 UTC |
Klompas Neil APresident & COO
|
Exercise / conversionCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-008432 · doc4.xml · nonDerivative · entry 1 Klompas Neil A · CIK 0001761857 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares of common stock issued upon vesting of one third of the restricted stock units ("RSUs") granted on March 10, 2020. Read SEC document |
| January 20, 2023 Filed Jan 23, 2023 23:00 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseCommon Stock | 163,400 | $9.88 | $1,615,094.62 |
DisclosureSEC source: 0001567619-23-001148 · doc1.xml · nonDerivative · entry 2 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 9,887,473 F4 · shares: Qualified Fund purchased 153,906 shares of the Common Stock acquired in this transaction. F5 · balance_after: After this transaction, Qualified Fund directly owned 9,312,162 shares of Common Stock. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The Filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| January 19, 2023 Filed Jan 23, 2023 23:00 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseCommon Stock | 144,100 | $9.49 | $1,367,638.69 |
DisclosureSEC source: 0001567619-23-001148 · doc1.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 9,724,073 F2 · shares: Qualified Fund purchased 135,728 shares of the Common Stock acquired in this transaction. F3 · balance_after: After this transaction, Qualified Fund directly owned 9,158,256 shares of Common Stock. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The Filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| January 18, 2023 Filed Jan 18, 2023 23:27 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseCommon Stock | 203,000 | $10.00 | $2,029,045.90 |
DisclosureSEC source: 0001567619-23-000997 · doc1.xml · nonDerivative · entry 3 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 9,579,973 F6 · shares: Qualified Fund purchased 191,206 shares of the Common Stock acquired in this transaction. F7 · balance_after: After this transaction, Qualified Fund directly owned 9,022,528 shares of Common Stock. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The Filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 23:27 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseCommon Stock | 440,000 | $9.80 | $4,313,848.00 |
DisclosureSEC source: 0001567619-23-000997 · doc1.xml · nonDerivative · entry 2 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 9,376,973 F4 · shares: Qualified Fund purchased 414,436 shares of the Common Stock acquired in this transaction. F5 · balance_after: After this transaction, Qualified Fund directly owned 8,831,322 shares of Common Stock. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The Filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| January 13, 2023 Filed Jan 18, 2023 23:27 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseCommon Stock | 342,100 | $9.81 | $3,354,632.60 |
DisclosureSEC source: 0001567619-23-000997 · doc1.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 8,936,973 F2 · shares: Qualified Fund purchased 322,224 shares of the Common Stock acquired in this transaction. F3 · balance_after: After this transaction, Qualified Fund directly owned 8,416,886 shares of Common Stock. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The Filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| January 11, 2023 Filed Jan 12, 2023 21:47 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseCommon Stock | 106,300 | $7.87 | $836,910.53 |
DisclosureSEC source: 0001567619-23-000896 · doc1.xml · nonDerivative · entry 2 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 8,594,873 F4 · shares: Qualified Fund purchased 100,124 shares of the Common Stock acquired in this transaction. F5 · balance_after: After this transaction, Qualified Fund directly owned 8,094,662 shares of Common Stock. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The Filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 21:47 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseCommon Stock | 920,000 | $7.65 | $7,037,172.00 |
DisclosureSEC source: 0001567619-23-000896 · doc1.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 8,488,573 F2 · shares: Qualified Fund purchased 861,156 shares of the Common Stock acquired in this transaction. F3 · balance_after: After this transaction, Qualified Fund directly owned 7,994,538 shares of Common Stock. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The Filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 20:00 UTC |
Galbraith KennethDirector · Chair & CEO
|
GrantRestricted Stock Unit · Derivative | 143,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-001217 · doc4.xml · derivative · entry 2 Galbraith Kenneth · CIK 0001567045 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,000 Underlying: Common Stock · 143,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs vest in three equal annual installments beginning on January 5, 2024. F3 · derivative.expiration_date: The RSUs vest in three equal annual installments beginning on January 5, 2024. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 20:00 UTC |
Galbraith KennethDirector · Chair & CEO
|
GrantStock Option (Right to Buy) · Derivative | 215,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0000899243-23-001217 · doc4.xml · derivative · entry 1 Galbraith Kenneth · CIK 0001567045 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,000 Underlying: Common Stock · 215,000 shares Expires 2033-01-04 F1 · derivative.exercise_date: Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 20:00 UTC |
Astle ChristopherSVP & Chief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 31,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-001218 · doc4.xml · derivative · entry 2 Astle Christopher · CIK 0001915257 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,500 Underlying: Common Stock · 31,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs vest in three equal annual installments beginning on January 5, 2024. F3 · derivative.expiration_date: The RSUs vest in three equal annual installments beginning on January 5, 2024. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 20:00 UTC |
Astle ChristopherSVP & Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 47,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0000899243-23-001218 · doc4.xml · derivative · entry 1 Astle Christopher · CIK 0001915257 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,000 Underlying: Common Stock · 47,000 shares Expires 2033-01-04 F1 · derivative.exercise_date: Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 20:00 UTC |
Klompas Neil APresident & COO
|
GrantRestricted Stock Unit · Derivative | 58,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-001219 · doc4.xml · derivative · entry 2 Klompas Neil A · CIK 0001761857 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,500 Underlying: Common Stock · 58,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs vest in three equal annual installments beginning on January 5, 2024. F3 · derivative.expiration_date: The RSUs vest in three equal annual installments beginning on January 5, 2024. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 20:00 UTC |
Klompas Neil APresident & COO
|
GrantStock Option (Right to Buy) · Derivative | 87,500 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0000899243-23-001219 · doc4.xml · derivative · entry 1 Klompas Neil A · CIK 0001761857 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 87,500 shares Expires 2033-01-04 F1 · derivative.exercise_date: Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.